SYMEX CORP has a total of 16 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, measurement and organic fine chemistry are LASERGEN INC, INTERGEN COMPANY and IBBEX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Organic fine chemistry | |
#4 | Pharmaceuticals | |
#5 | Foods and drinks | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Sugars | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Medical preparations | |
#6 | Enzymes | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Maher James F | 16 |
#2 | Clinkscales C Worth | 16 |
#3 | Roark Michael D | 11 |
#4 | Turner Gregory A | 10 |
#5 | Liav Avraham | 4 |
#6 | Shimasaki Craig D | 4 |
#7 | Roark Michael C | 3 |
Publication | Filing date | Title |
---|---|---|
US5252458A | Method for visually detecting the presence of a virus in a clinical specimen | |
AU7176191A | Chromogenic 5-position modified neuraminic acid substrates and methods for diagnosing human influenza therewith | |
AU7150891A | Chromogenic 9-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith | |
AU7161591A | Stable formulation of viral neuraminidase | |
EP0507854A1 | Methods for diagnosing human influenza and 4-position modified chromogenic n-acetylneuraminic acid substrates for use therein | |
AU7176091A | Chromogenic 7- or 8-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith |